4.7 Article

Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in Culture

期刊

CELL STEM CELL
卷 8, 期 1, 页码 106-118

出版社

CELL PRESS
DOI: 10.1016/j.stem.2010.12.003

关键词

-

资金

  1. NIH/NICHD
  2. Hartwell Foundation
  3. CIRM [CL1-00502, RT1-01108, TR1-01250, RN2-00931-1]
  4. NIH [R21MH087925, R01 HL64387, P01 HL094374, R01 HL084642, P01 GM081719]
  5. Millipore Foundation
  6. Esther O'Keefe Foundation
  7. Edmond J. Safra foundation in Tel Aviv University
  8. Legacy stem cell research fund
  9. PEW Charitable Trust
  10. Ministry of Education, Science and Technology [SC2250]
  11. Ministerio de Ciencia e Innovacion of Spain [RYC-2007-01510, SAF2009-08588]
  12. MICINN Fundacion Cellex
  13. G. Harold and Leila Y. Mathers Charitable Foundation
  14. Sanofi-Aventis
  15. NHLBI [RC1HL100168]
  16. Israel Science Foundation [802/08]
  17. Australian Stem Cell Centre
  18. Victoria-California Stem Cell Alliance, CIRM [TR101250]
  19. Victoria-California Stem Cell Alliance, state government of Victoria, Australia [TR101250]

向作者/读者索取更多资源

Genomic stability is critical for the clinical use of human embryonic and induced pluripotent stem cells. We performed high-resolution SNP (single-nucleotide polymorphism) analysis on 186 pluripotent and 119 nonpluripotent samples. We report a higher frequency of subchromosomal copy number variations in pluripotent samples compared to nonpluripotent samples, with variations enriched in specific genomic regions. The distribution of these variations differed between hESCs and hiPSCs, characterized by large numbers of duplications found in a few hESC samples and moderate numbers of deletions distributed across many hiPSC samples. For hiPSCs, the reprogramming process was associated with deletions of tumor-suppressor genes, whereas time in culture was associated with duplications of oncogenic genes. We also observed duplications that arose during a differentiation protocol. Our results illustrate the dynamic nature of genomic abnormalities in pluripotent stem cells and the need for frequent genomic monitoring to assure phenotypic stability and clinical safety.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据